↓ Skip to main content

Dove Medical Press

Article Metrics

Clinical utility of eslicarbazepine: current evidence

Overview of attention for article published in Drug Design, Development and Therapy, February 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
46 Mendeley
Title
Clinical utility of eslicarbazepine: current evidence
Published in
Drug Design, Development and Therapy, February 2015
DOI 10.2147/dddt.s57409
Pubmed ID
Authors

Gaetano Zaccara, Fabio Giovannelli, Massimo Cincotta, Alessia Carelli, Alberto Verrotti

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 2%
Portugal 1 2%
Switzerland 1 2%
Unknown 43 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 17%
Professor > Associate Professor 6 13%
Student > Ph. D. Student 6 13%
Researcher 5 11%
Professor 4 9%
Other 9 20%
Unknown 8 17%
Readers by discipline Count As %
Medicine and Dentistry 14 30%
Chemistry 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Psychology 3 7%
Neuroscience 3 7%
Other 7 15%
Unknown 11 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2017.
All research outputs
#3,299,285
of 11,700,978 outputs
Outputs from Drug Design, Development and Therapy
#212
of 1,236 outputs
Outputs of similar age
#92,483
of 251,897 outputs
Outputs of similar age from Drug Design, Development and Therapy
#4
of 34 outputs
Altmetric has tracked 11,700,978 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,236 research outputs from this source. They receive a mean Attention Score of 3.8. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,897 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.